CUP: E89I21000100006
(A19_POR-FESR-2014-2020_2021_FD132723) FARMACI PER COVID
SUMMARY OF THE PROJECT
(A19_POR-FESR-2014-2020_2021_FD132723) FARMACI PER COVID
Download project
Funding monitored
€ 416,924.68
of which cohesion funds
€ 416,924.68
| Given name | Amount |
|---|---|
| European Union | 208462.34 |
| Revolving Fund | 145923.64 |
| Region | 62538.70 |
Payments monitored
€ 416,924.68
of which cohesion funds
€ 416,924.68
| Year | Amount | Cumulative amount | Percentage on public financing |
|---|---|---|---|
| 2021 | 384730.72 | 384730.72 | 92 |
| 2022 | 32193.96 | 416924.68 | 100 |
State of progress
Completed
Expected start: 01/01/2021
Effective start: 01/01/2021
Expected end: 31/12/2021
Effective end: 06/07/2022
Entities
- Planning body
- REGIONE PIEMONTE
- Implementing body
- REGIONE PIEMONTE
- Beneficiary
- AZIENDA OSPEDALIERO UNIVERSITARIA S LUIGI GONZAGA
- Executor
-
TILLOMED ITALIA
TECHDOW PHARMA ITALY
SOL
SANOFI
PFIZER
MSD ITALIA
FRESENIUS KABI ITALIA
FARMACEUTICA INTERNAZIONALE ITALIANA
EUROMED
ELI LILLY ITALIA
Visualizzati i primi 10 soggetti di 12
Programming area
- European Regional Development Fund (ERDF)
- 2014-2020 EU Structural Funds
- Programme
- ROP ERDF PIEDMONT
- Axis
- RICERCA, SVILUPPO TECNOLOGICO E INNOVAZIONE
- Specific objective
- Promuovere gli investimenti necessari per il rafforzamento della capacità di risposta alla crisi nei servizi sanitari